| human | Q5 |
| P496 | ORCID iD | 0000-0003-1076-359X |
| P108 | employer | FIRC Institute of Molecular Oncology | Q30252791 |
| National Cancer Institute | Q3747179 | ||
| P735 | given name | Valeria | Q7385728 |
| Valeria | Q7385728 | ||
| P106 | occupation | researcher | Q1650915 |
| Q53355540 | A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project. |
| Q35618307 | An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers |
| Q35957703 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer |
| Q61970278 | Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers |
| Q35091400 | Characterization of an Italian founder mutation in the RING-finger domain of BRCA1. |
| Q36839777 | Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q58813401 | Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation |
| Q51016187 | Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability. |
| Q33614244 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers |
| Q35999309 | FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q44415170 | Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q27008356 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk |
| Q54562204 | Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. |
| Q97414999 | HPV nonrelated endocervical adenocarcinoma in hereditary cancer syndromes |
| Q31043651 | Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q35984974 | Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study |
| Q54396803 | No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women. |
| Q41507618 | Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy |
| Q112699733 | OncoPan®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma |
| Q99213670 | Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q60315457 | The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases |
| Q51296900 | X chromosome inactivation pattern in BRCA gene mutation carriers. |
Search more.